News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Rezolute, Inc.
NEWS
JOBS
IN THE PRESS
NEWS
Drug Development
Clinical Catch-Up: Moderna COVID-19 Vaccine for Kids and Much More
Although it was relatively quiet in COVID-19-related clinical trials, there was plenty of other clinical trial news. Here’s a look.
March 25, 2022
·
10 min read
·
Mark Terry
Business
BioSpace Movers & Shakers, March 12
Biopharma and life sciences companies strengthen their leadership teams and boards with these Movers & Shakers.
March 11, 2021
·
7 min read
·
Alex Keown
JOBS
Currently, there are no jobs for this company on BioSpace
Browse all jobs
here
Oops!
There was an issue retrieving the jobs list. Please reload the page to view more jobs.
Title
Location
Company Name
Desc
View details
IN THE PRESS
Press Releases
Rezolute Reports First Quarter Fiscal 2025 Financial Results and Provides Business Update
November 8, 2024
·
6 min read
Press Releases
Rezolute to Participate in Upcoming November 2024 Investor Conferences
November 6, 2024
·
1 min read
Business
Rezolute Reports Fourth Quarter and Full Year Fiscal 2024 Financial Results and Provides Business Update
September 19, 2024
·
8 min read
Press Releases
Rezolute to Participate in Upcoming Investor Conferences
August 27, 2024
·
1 min read
Press Releases
Rezolute Announces FDA Clearance of IND Application for Phase 3 Registrational Study of RZ358 for Treatment of Hypoglycemia Due to Tumor Hyperinsulinism
August 5, 2024
·
5 min read
Press Releases
Rezolute to Participate in the BTIG Virtual Biotechnology Conference
July 31, 2024
·
1 min read
Pharm Country
Rezolute Announces Exercise of Underwriters’ Option to Purchase Additional Shares and Concurrent Private Placement
June 27, 2024
·
4 min read
Pharm Country
Rezolute Announces Closing of Public Offering with Approximately $60M in Gross Proceeds
June 24, 2024
·
4 min read
Pharm Country
Rezolute Announces Pricing of Public Offering of $60 Million of Common Stock and Pre-Funded Warrants
June 13, 2024
·
4 min read
Pharm Country
Rezolute Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants - June 13, 2024
June 13, 2024
·
4 min read